The study concluded that dupilumab may unmask or progress CTCL through IL13 receptor blockade, like its effect in atopic dermatitis. However, further evaluation is needed due to the limitations of the ...

Keywords: monoclonal antibodies, mAbs, antibody structure and function, antibody-based therapeutics, nanobodies, bispecific antibodies, antibody engineering, respiratory infections, influenza, ...

There are a number of key terms that apply to organisational structures: ...